JOHN PETER MCLAUGHLIN Insider Trading $ADVM Adverum Biotechnologies, Inc.
Get free email notifications about insider trading for JOHN PETER MCLAUGHLIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN PETER MCLAUGHLIN. JOHN PETER MCLAUGHLIN is CEO in PDL BIOPHARMA, INC. ($PDLI) and Director in PDL BIOPHARMA, INC. ($PDLI) and President, CEO in PDL BIOPHARMA, INC. ($PDLI) and Director in ROCKWELL MEDICAL, INC. ($RMTI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Chief Executive Officer in ANESIVA, INC. ($CGTK) and President & CEO in ANESIVA, INC. ($CGTK) and Director in LENSAR, Inc. ($LNSR) and Director in Adverum Biotechnologies, Inc. ($AAVL).
JOHN PETER MCLAUGHLIN in Adverum Biotechnologies, Inc.
Trading Symbol: ADVMIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOHN PETER MCLAUGHLIN: Director
Holdings: 10,333 shares
Latest Transaction: Feb 17 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOHN PETER MCLAUGHLIN in Adverum Biotechnologies, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADVM, CGTK, LNSR, PDLI, RMTI, SGEN
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 17 2016 | AAVL | Adverum Biotechnol ... | MCLAUGHLIN JOHN PETER | Director | Option Exercise | A | 4.80 | 11,905 | 57,144 | 11,905 | |
Feb 17 2016 | AAVL | Adverum Biotechnol ... | MCLAUGHLIN JOHN PETER | Director | Grant | A | 0.00 | 8,333 | 0 | 10,333 | 2 K to 10.3 K (+416.65 %) |
Apr 23 2015 | AAVL | Adverum Biotechnol ... | MCLAUGHLIN JOHN PETER | Director | Option Exercise | A | 39.35 | 7,000 | 275,450 | 7,000 | |
Apr 23 2015 | AAVL | Adverum Biotechnol ... | MCLAUGHLIN JOHN PETER | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
Page: 1